EQ - 相关文章

21 CFR Part 333 Subpart B - First Aid Antibiotic Drug Products

21CFR 2026-07-27

21 CFR Part 333 Subpart B - First Aid Antibiotic Drug ProductsSubpart B—First Aid Antibiotic Drug Products§ 333.101 Scope.(a) An over-the-counter first aid antibiotic drug product in a form suitable for topical administration is generally recognized

21 CFR Part 332 - Antiflatulent Products for Over-the-Counter Human Use

21CFR 2026-07-27

21 CFR Part 332 - Antiflatulent Products for Over-the-Counter Human UsePART 332—ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USEAuthority:21 U.S.C. 321, 351, 352, 353, 355, 360, 371.Source:39 FR 19877, June 4, 1974, unless otherwise noted.Subpar

21 CFR Part 333 Subpart C—Topical Antifungal Drug Products

21CFR 2026-07-27

21 CFR Part 333 Subpart C—Topical Antifungal Drug ProductsSubpart C—Topical Antifungal Drug ProductsSource:58 FR 49898, Sept. 23, 1993, unless otherwise noted.§ 333.201 Scope.(a) An over-the-counter antifungal drug product in a form suitable for topi

21 CFR Part 347 - Skin Protectant Drug Products for Over-the-Counter Human Use

21CFR 2026-07-27

21 CFR Part 347 - Skin Protectant Drug Products for Over-the-Counter Human UsePART 347—SKIN PROTECTANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USEAuthority:21 U.S.C. 321, 351, 352, 353, 355, 360, 371.Source:58 FR 54462, Oct. 21, 1993, unless otherwi

21 CFR Part 333 Subpart D—Topical Acne Drug Products

21CFR 2026-07-27

21 CFR Part 333 Subpart D—Topical Acne Drug ProductsSubpart D—Topical Acne Drug ProductsSource:56 FR 41019, Aug. 16, 1991, unless otherwise noted.§ 333.301 Scope.(a) An over-the-counter acne drug product in a form suitable for topical application is

21 CFR Part 350 - Antiperspirant Drug Products for Over-the-Counter Human Use

21CFR 2026-07-27

21 CFR Part 350 - Antiperspirant Drug Products for Over-the-Counter Human UsePART 350—ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USEAuthority:21 U.S.C. 321, 351, 352, 353, 355, 360, 371.Source:68 FR 34291, June 9, 2003, unless otherwise

21 CFR Part 352 - Sunscreen Drug Products for Over-the-Counter Human Use [Stayed Indefinitely]

21CFR 2026-07-27

21 CFR Part 352 - Sunscreen Drug Products for Over-the-Counter Human Use [Stayed Indefinitely]PART 352—SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY]Authority:21 U.S.C. 321, 351, 352, 353, 355, 360, 371.Source:64 FR 2768

21 CFR Part 355 - Anticaries Drug Products for Over-the-Counter Human Use

21CFR 2026-07-27

21 CFR Part 355 - Anticaries Drug Products for Over-the-Counter Human UsePART 355—ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USEAuthority:21 U.S.C. 321, 351, 352, 353, 355, 360, 371.Source:60 FR 52507, Oct. 6, 1995, unless otherwise noted.Ed

FDA将NDC编号从10位统一升级为12位：出口企业合规过渡要点解析

NDC申报 2026-07-13

2026年3月5日FDA发布最终规则，将NDC编号从现行10位格式统一升级为12位标准格式（6-4-2），2033年3月7日正式生效，设有3年过渡期。所有OTC药品包括防晒霜、祛痘产品等功能性化妆品的NDC注册编号均须完成转换，企业应在过渡期内完成IT系统升级、标签更新与供应链协调。